Sisram Medical Ltd 2019 AR2
The report outlines Sisram Medical Ltd's financial and operational performance for the fiscal year 2019. The company achieved a total revenue of US$173.5 million, representing a 12.7% increase year-over-year, driven by strong sales in its core and minimally invasive product lines. Key highlights include the successful commercial launch of the Soprano Titanium laser hair removal platform and the acquisition of a 60% equity interest in Nova Medical Israel Ltd. to consolidate its distribution network. Sisram also expanded its global footprint by establishing new direct sales offices in Israel, Australia, and South Korea.
Company: Sisram Medical Ltd
Sector: Manufacturing
Country: Israel
Year: 2019
Type: AR2
Pages: 141
Back to company
Sisram Medical Ltd
Annual Report
The report outlines Sisram Medical Ltd's financial and operational performance for the fiscal year 2019. The company achieved a total revenue of US$173.5 million, representing a 12.7% increase year-over-year, driven by strong sales in its core and minimally invasive product lines. Key highlights include the successful commercial launch of the Soprano Titanium laser hair removal platform and the acquisition of a 60% equity interest in Nova Medical Israel Ltd. to consolidate its distribution network. Sisram also expanded its global footprint by establishing new direct sales offices in Israel, Australia, and South Korea.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Jan 1, 2019 - Dec 31, 2019
Fiscal Year
2019
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees